Skip to content
Call organization(425) 818-5333
Non-clinical specialist

Tony Hsu

Chief Executive Officer · 3X4 GeneticsConsumer genetic testing, Health-tech venture investment, Board leadership, Company operations

Investor turned operator who led the 2019 round that moved a nutrigenomics testing company to the US, then stepped into the CEO seat in 2022

View the practiceSource profileCredentials checked
Portrait of Tony Hsu

Practice

About

Tony Hsu arrived at 3X4 Genetics as its investor before he arrived as its manager. His firm Alethea Capital Management led the company's 2019 venture round, and he chaired the board for three years before taking the CEO seat in August 2022. He founded Alethea in 2011 after a trading and portfolio-management career that ran through Lehman Brothers, Deutsche Bank, UBS and Oppenheimer & Co., and steered the firm toward early-stage biotech and health-tech. He holds a BA in political science from UCLA, and co-founded the San Diego non-profit Just In Time For Foster Youth.

Approach

Signature approach

Hsu runs 3X4 the way its board chair would: capital, partnerships, and channel reach rather than science. Under him the company launched GENEFIT, a sports-performance division pairing genetic pathway data with wearable-tracker data, and signed the practitioner networks that route the test to clinicians. The scientific and clinical work sits with his product and dietitian leads.

What sets them apart

  • Capital-first entry. The 2019 Alethea round he led required 3X4 to move its intellectual property and corporate home from South Africa to the United States. That is why the company is a Washington business rather than a Cape Town one.
  • Two chief-executive seats at once. He runs Alethea Capital Management, the venture firm he founded in 2011, concurrently with 3X4.
  • A biotech board record behind him. Alethea's early-stage focus put him on the board of Avidity Biosciences at its 2017 Series B.

Training

Education

  • BA, Political Science (International Relations emphasis)
    University of California, Los Angeles
  • Stanford University

Elsewhere

Media and talks

Collaboration

  • Alethea Capital Management
    Founder and Chief Investment Officer since 2011; the firm led the 2019 investment that relocated 3X4 Genetics to the United States, and he holds this role concurrently with the 3X4 CEO seat
  • Avidity Biosciences
    Joined the board as a non-voting member at the company's January 2017 Series B, in which Alethea Capital participated
  • Just In Time For Foster Youth
    Co-founder of the San Diego non-profit serving emancipated foster youth
  • Find Ventures
    Seed investor and advisory board member at the Seattle 501(c)(3) providing early-stage funding to under-represented entrepreneurs
  • University of San Diego Nonprofit Institute
    Co-chair of the Advisory Board, 2012-2017

Verification

Profile updated
Credentials checked
Affiliations verified

Primary sourcehttps://3x4genetics.com/pages/about-us

Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.